Alambic Investment Management, L.P. - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 191 filers reported holding ARRAY BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2018$440,000
+32.9%
26,200
-2.7%
0.12%
+236.1%
Q3 2017$331,000
-7.0%
26,923
-36.7%
0.04%
-16.3%
Q2 2017$356,000
-79.6%
42,542
-78.2%
0.04%
-80.0%
Q1 2017$1,744,000
+14.5%
195,030
+12.6%
0.22%
-20.4%
Q4 2016$1,523,000
+18.1%
173,230
-9.4%
0.27%
-10.9%
Q3 2016$1,290,000
+148.6%
191,130
+31.1%
0.30%
+133.1%
Q2 2016$519,000
+222.4%
145,788
+167.0%
0.13%
+150.0%
Q1 2016$161,000
+6.6%
54,600
+52.1%
0.05%
-42.9%
Q4 2015$151,00035,9000.09%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2017
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders